Host control of Mycobacterium tuberculosis is regulated by 5-lipoxygenase-dependent lipoxin production

被引:195
作者
Bafica, A
Scanga, CA
Serhan, C
Machado, F
White, S
Sher, A
Aliberti, J
机构
[1] Duke Univ, Med Ctr, Sch Med, Dept Immunol, Durham, NC 27710 USA
[2] NIAID, Immunobiol Sect, Parasit Dis Lab, Bethesda, MD 20892 USA
[3] Fdn Oswaldo Cruz, Lab Imunorregulacao & Microbiol, Ctr Pesquisas Goncalo Moinz, Salvador, BA, Brazil
[4] Harvard Univ, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med,Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1172/JCI23949
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Th1 type cytokine responses are critical in the control of Mycobacterium tuberculosis infection. Recent findings indicate that 5-lipoxygenase-dependent(5-LO-dependent) lipoxins regulate host IL-12 production in vivo. Here, we establish lipoxins as key chemical mediators in resistance to M. tuberculosis infection. High levels of lipoxin A(4) (LXA(4)) were detected in sera from infected WT but not infected 5-LO-deficient mice. Moreover, lungs from M. tuberculosis-infected 5-16(-/-) animals showed increased IL-12, IFN-gamma, and NO synthase 2 (NOS2) mRNA levels compared with the same tissues in WT mice. Similarly, splenocyte recall responses were enhanced in mycobacteria-infected 5-lo(-/-) versus WT mice. Importantly, bacterial burdens in 5-lo(-/-) lungs were significantly lower than those from WT mice, and this enhancement in the resistance of the 5-lo(-/-) animals to M. tuberculosis was completely prevented by administration of a stable LXA4 analog. Together our results demonstrate that lipoxins negatively regulate protective Th1 responses against mycobacterial infection in vivo and suggest that the inhibition of lipoxin biosynthesis could serve as a strategy for enhancing host resistance to M. tuberculosis.
引用
收藏
页码:1601 / 1606
页数:6
相关论文
共 30 条
[1]   Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity [J].
Aliberti, J ;
Hieny, S ;
Sousa, CRE ;
Serhan, CN ;
Sher, A .
NATURE IMMUNOLOGY, 2002, 3 (01) :76-82
[2]   Host persistence:: Exploitation of anti-inflammatory pathways by Toxoplasma gondii [J].
Aliberti, J .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (02) :162-170
[3]   Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection [J].
Aliberti, J ;
Serhan, C ;
Sher, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (09) :1253-1262
[4]   Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency [J].
Altare, F ;
Durandy, A ;
Lammas, D ;
Emile, JF ;
Lamhamedi, S ;
Le Deist, F ;
Drysdale, P ;
Jouanguy, E ;
Döffinger, R ;
Bernaudin, F ;
Jeppsson, O ;
Gollob, JA ;
Meinl, E ;
Segal, AW ;
Fischer, A ;
Kumararatne, D ;
Casanova, JL .
SCIENCE, 1998, 280 (5368) :1432-1435
[5]   Cutting edge:: Lipoxin (LX) A4 and aspirin-triggered 15-Epi-LXA4 block allergen-induced eosinophil trafficking [J].
Bandeira-Melo, C ;
Bozza, PT ;
Diaz, BL ;
Cordeiro, RSB ;
Jose, PJ ;
Martins, MA ;
Serhan, CN .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2267-2271
[6]   Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration [J].
Bannenberg, G ;
Moussignac, RL ;
Gronert, K ;
Devchand, PR ;
Schmidt, BA ;
Guilford, WJ ;
Bauman, JG ;
Subramanyam, B ;
Perez, HD ;
Parkinson, JF ;
Serhan, CN .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (01) :43-52
[7]   Exogenous pathogen and plant 15-lipoxygenase initiate endogenous lipoxin A4 biosynthesis [J].
Bannenberg, GL ;
Aliberti, J ;
Hong, S ;
Sher, A ;
Serhan, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (04) :515-523
[8]   Lipid mediator-induced expression of bactericidal/permeability-increasing protein (BPI) in human mucosal epithelia [J].
Canny, G ;
Levy, O ;
Furuta, GT ;
Narravula-Alipati, S ;
Sisson, RB ;
Serhan, CN ;
Colgan, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) :3902-3907
[9]   Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo [J].
Clish, CB ;
O'Brien, JA ;
Gronert, K ;
Stahl, GL ;
Petasis, NA ;
Serhan, CN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) :8247-8252
[10]  
COOPER AM, 1995, IMMUNOLOGY, V84, P423